Clinical Results of Small Incision Lenticule Extraction (SMILE) for the Correction of High Myopia
Launched by SUPHI TANERI · Sep 30, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a procedure called Small Incision Lenticule Extraction (SMILE), which is used to correct high myopia (nearsightedness) in adults. The SMILE technique uses a special laser to create a small disk of tissue in the eye, which is then removed through a tiny incision. This method aims to provide quick recovery of vision with minimal discomfort. The trial is observing long-term results and stability of vision correction in patients with myopia greater than -7.75 diopters, while also looking out for any rare complications that may occur.
To be eligible for this trial, participants need to be adults with high myopia (more than -7.75 D) and have stable vision for at least a year. Unfortunately, individuals with certain eye conditions, like irregular astigmatism or corneal ectasia, cannot participate. Those who join the study can expect to undergo the SMILE procedure and have their vision monitored over time to evaluate how well the treatment works. Overall, this trial will help gather important information about the safety and effectiveness of SMILE for correcting high myopia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adults
- • myopia more than -7.75 D
- • refractive stability more than 1 year
- Exclusion Criteria:
- • corneal irregular astigmatism
- • ectatic conditions
About Suphi Taneri
Suphi Taneri is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on integrity and scientific excellence, the organization collaborates with leading research institutions and healthcare professionals to design and implement rigorous clinical trials across various therapeutic areas. Suphi Taneri prioritizes patient safety and ethical standards, ensuring that all trials are conducted in accordance with regulatory guidelines. Through its strategic approach and commitment to quality, Suphi Taneri aims to contribute significantly to the development of groundbreaking treatments and enhance the understanding of complex medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Münster, Nrw, Germany
Patients applied
Trial Officials
Suphi Taneri, MD
Study Chair
Center for Refractive Surgery Muenster
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials